To Determine Tolerability and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures

Partial Epilepsies Clinical Trial

Official title:
An Open-label Extension Trial to Determine Tolerability and Efficacy of Long-term Oral SPM 927 as Adjunctive Therapy in Patients With Partial Seizures

Status Completed

Clinical Trial Summary

The purpose of this trial is to determine whether lacosamide is safe and effective for long-term use in patients with partial-seizures from epilepsy.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00552305
Study type	Interventional
Source	UCB Pharma
Contact
Status	Completed
Phase	Phase 2
Start date	August 2001
Completion date	February 2010

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00522275` - Determine Safety and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures	Phase 3
Completed	`NCT01235403` - Trial to Assess Optimized Dosage of Lacosamide as add-on Therapy in Patients With Partial Onset Seizure	Phase 4
Completed	`NCT00955357` - Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures	Phase 4
Completed	`NCT00655486` - Study to Assess the Long-term Safety of Oral Lacosamide in Subjects With Partial-onset Seizures	Phase 3
Completed	`NCT00655551` - Safety of Intravenous Lacosamide Dose Followed by Twice Daily Oral Lacosamide in Subjects With Partial-onset Seizures	Phase 3